Search Results - Grob, Jean-jaques

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    545 A phase 2 study of retifanlimab in patients with advanced or metastatic merkel cell carcinoma (MCC) (POD1UM-201)

    545 A phase 2 study of retifanlimab in patients with advanced or metastatic merkel cell carcinoma (MCC) (POD1UM-201) by Grignani, Giovanni, Rutkowski, Piotr, Lebbe, Celeste, Prinzi, Natalie, Grob, Jean-jaques, Tanda, Enrica Teresa, Guida, Michele, Burgess, Melissa, Pulini, Jennifer, Shankar, Sadhna, Tian, Chuan, Bhatia, Shailender

    Request full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    547 CERPASS: A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma

    547 CERPASS: A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma by Haydon, Andrew, Alamgeer, Muhammad, Brungs, Daniel, Collichio, Frances, Khushalani, Nikhil, Colevas, Dimitrios, Rischin, Danny, Kudchadkar, Ragini, Chai-Ho, Wanxing, Daniels, Gregory, Lutzky, Jose, Lee, Jenny, Bowyer, Samantha, Migden, Michael, Silk, Ann, Lebbe, Celeste, Grob, Jean-jaques, Melero, Ignacio, Sheladia, Piyush, Bommareddy, Praveen, He, Shui, Andreu-Vieyra, Claudia, Fury, Matthew, Hill, Andrew

    Request full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in patients (pts) at high risk for recurrence

    A Phase III study (CheckMate 238) of adjuvant immunotherapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage IIIb/c or stage IV melanoma (MEL) in pat... by Weber, Jeffrey, Grob, Jean-Jaques, Margolin, Kim A, Ascierto, Paolo A, Sznol, Mario, Ott, Patrick A, Lejeune, Chantal, de Pril, Veerle, Ruisi, Mary M, Hodi, F Stephen

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    604 First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from the JAVELIN Merkel 200 trial

    604 First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from the JAVELIN Merkel 200 trial by D'Angelo, Sandra, Lebbé, Celeste, Mortier, Laurent, Brohl, Andrew, Fazio, Nicola, Jean-jaques Grob, Prinzi, Natalie, Hanna, Glenn, Hassel, Jessica, Kiecker, Felix, Anja von Heydebreck, Güzel, Gülseren, Nghiem, Paul

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    A Phase III study at high risk for recurrence

    A Phase III study at high risk for recurrence by Weber, Jeffrey, Grob, Jean-Jaques, Margolin, Kim A, Ascierto, Paolo A, Sznol, Mario, Ott, Patrick A, Lejeune, Chantal, de Pril, Veerle, Ruisi, Mary M, Hodi, F Stephen

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Visual perception and the challenge of being visually literate

    Visual perception and the challenge of being visually literate by Naldi, Luigi, Grob, Jean-Jaques

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: